Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Non-Current Assets (2024 - 2025)

BioAge Labs (BIOA) has disclosed Non-Current Assets for 2 consecutive years, with $8.1 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets rose 615.83% to $8.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $61.8 million through Dec 2025, changed N/A year-over-year, with the annual reading at $8.1 million for FY2025, 615.83% up from the prior year.
  • Non-Current Assets hit $8.1 million in Q4 2025 for BioAge Labs, down from $14.3 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $20.5 million in Q2 2025 to a low of $914000.0 in Q3 2024.